Subscribe

Risk Score of Harigai et al for Pneumocystis Pneumonia in a Patient with Rheumatoid Arthritis Treated with Infliximab

Purpose:

To determine the risk of pneumocystis pneumonia in a patient with rheumatoid arthritis being treated with infliximab using the score of Harigai et al.

Specialty:

Infectious Diseases

Objective:

risk factors, severity, prognosis, stage

ICD-10:

B59, M05

Description:

Harigai et al identified risk factors associated with cumulative risk of a patient with rheumatoid arthritis being treated with infliximab developing pneumocystis pneumonia. The authors are from the Tokyo Medical and Dental University.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone